OverviewChartNewsTraderScreen

UniCredit Discount Zert 22UA 27.0.../  DE000HD1NMP1  /

EUWAX
06/08/2024  09:49:50 Chg.+0.76 Bid06/08/2024 Ask06/08/2024 Underlying Strike price Expiration date Option type
67.80EUR +1.13% 67.80
Bid Size: 300		 67.98
Ask Size: 300		 BIONTECH SE SPON. AD... - - 27/06/2025 Call
TeleTrader 05/08 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 27/06 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 24/06 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 01/06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
TeleTrader 06/05 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
TeleTrader 20/03 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07/03 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 06/03 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 08/02 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 31/01 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 22/01 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...
TeleTrader 09/01 BioNTech sees $3.3B revenue for 2024, expanding into oncology
GlobeNewswire 09/01 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 21/12/2023 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 18/12/2023 BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
GlobeNewswire 12/12/2023 BioNTech to Inaugurate First African Site on December 18, 2023